Wall Street Analysts See a 178.82% Upside in Tyra Biosciences ( TYRA ) : Can the Stock Really Move This High?
The average of price targets set by Wall Street analysts indicates a potential upside of 178.8% in Tyra Biosciences (TYRA). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Tyra Biosciences Narrows Loss in Q2
Tyra Biosciences ( NASDAQ:TYRA ) , a clinical-stage biotech company focused on therapies for FGFR ( fibroblast growth factor receptor ) conditions, released its second quarter results on August 14, 2025. The most notable news was a net loss per share of $ ( 0.47 ) ( GAAP ) .
Northrop Grumman Posts Downbeat Results, Joins Halliburton And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Celcuity ( NASDAQ:CELC ) , Five Point Hldgs ( NYSE:FPH )
U.S. stock futures were higher this morning, with the Dow futures gaining around 300 points on Tuesday. Shares of Northrop Grumman Corporation NOC shares fell sharply in today's pre-market trading after the company reported worse-than-expected first-quarter EPS and revenues.
Why Calix Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket - Calix ( NYSE:CALX ) , Adaptive Biotechnologies ( NASDAQ:ADPT )
Shares of Calix, Inc. CALX rose sharply in today's pre-market trading as the company reported better-than-expected first-quarter financial results and issued strong second-quarter guidance.
Why WaFd Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket - Alta Equipment Group ( NYSE:ALTG ) , Mobile Infrastructure ( AMEX:BEEP )
Shares of WaFd, Inc. WAFD rose sharply in today's pre-market trading following second-quarter results. WaFd posted quarterly GAAP EPS of 65 cents, beating market estimates of 58 cents. The company's quarterly sales came in at $179.79 million versus expectations of $157.81 million.
Why Penguin Solutions Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - American Rebel Holdings ( NASDAQ:AREB ) , Aptevo Therapeutics ( NASDAQ:APVO )
Shares of Penguin Solutions, Inc. PENG rose sharply in today's pre-market trading after the company posted better-than-expected results for its second quarter on Wednesday. The company said it sees FY25 net sales growth of 17% year-over-year +/-3% and adjusted EPS of $1.60 +/- $0.10.
Incyte, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Incyte ( NASDAQ:INCY ) , Affirm Holdings ( NASDAQ:AFRM )
U.S. stock futures were lower this morning, with the Dow futures falling around 100 points on Monday. Shares of Incyte Corporation INCY fell sharply in today's pre-market trading after reporting topline results from two Phase 3 clinical trials of Povorcitinib in patients with Hidradenitis ...
Why Precision BioSciences Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - Aspira Womens Health ( NASDAQ:AWH ) , Aclarion ( NASDAQ:ACON )
Shares of Precision BioSciences, Inc. DTIL rose sharply in today's pre-market trading. Precision BioSciences reported clearance of investigational new drug application by the U.S. FDA for first-in-class PBGENE-HBV designed to eliminate root cause of chronic hepatitis B.
Neumora Therapeutics, XPeng And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Celcuity ( NASDAQ:CELC ) , GrafTech International ( NYSE:EAF )
U.S. stock futures were higher this morning, with the Dow futures gaining more than 300 points on Thursday. Shares of Neumora Therapeutics, Inc. NMRA fell sharply in today's pre-market trading after the company reported data from KOASTAL-1 study of Navacaprant in major depressive disorder.
Why Is Cancer-Focused Tyra Biosciences Stock Falling On Friday? - Tyra Biosciences ( NASDAQ:TYRA )
On Thursday, Tyra Biosciences, Inc. TYRA released clinical proof-of-concept data for TYRA-300 in patients with metastatic urothelial ( mUC ) cancer from its ongoing SURF301 Phase 1/2 study. These data will be presented at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics.
BofA Upgrades Tyra Biosciences As Investors Focus On Preclinical Data Amid High Benchmarks Set By Johnson & Johnson's Drug - Tyra Biosciences ( NASDAQ:TYRA )
BofA Securities has upgraded Tyra Biosciences TYRA, a clinical-stage biotechnology company focused on developing next-generation precision medicines. The company's initial focus is on improving small molecule drug discovery and development in targeted oncology and genetically defined conditions.
This Datadog Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday - Datadog ( NASDAQ:DDOG )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. B of A Securities analyst Geoff Meacham upgraded the rating for Tyra Biosciences, Inc.
Wall Street Analysts Think Tyra Biosciences ( TYRA ) Could Surge 27.88%: Read This Before Placing a Bet
The consensus price target hints at a 27.9% upside potential for Tyra Biosciences (TYRA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Bank of New York Mellon Posts Upbeat Earnings, Joins Archer Aviation, Rivian Automotive And Other Big Stocks Moving Higher On Friday - Bank of New York Mellon ( NYSE:BK )
U.S. stocks were higher, with the Nasdaq Composite index gaining around 100 points on Friday. Shares of The Bank of New York Mellon Corporation BK rose during Friday's session following better-than-expected quarterly financial results.
Tyra Biosciences ( TYRA ) Upgraded to Buy: What Does It Mean for the Stock?
Tyra Biosciences (TYRA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Wall Street Analysts See a 27.27% Upside in Tyra Biosciences ( TYRA ) : Can the Stock Really Move This High?
The consensus price target hints at a 27.3% upside potential for Tyra Biosciences (TYRA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
S&P 500 Gains Over 1%; Amazon Earnings Top Expectations - Cingulate ( NASDAQ:CING ) , Amazon.com ( NASDAQ:AMZN )
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 1.8% on Friday. The Dow traded up 0.49% to 38,705.29 while the NASDAQ rose 1.81% to 15,639.81. The S&P 500 also rose, gaining, 1.20% to 4,965.03. Communication services shares rose by 4.1% on Friday.
Nasdaq Rises Over 200 Points; Apple Posts Upbeat Earnings - Cingulate ( NASDAQ:CING ) , Apple ( NASDAQ:AAPL )
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 200 points on Friday. The Dow traded up 0.19% to 38,593.49 while the NASDAQ rose 1.55% to 15,600.39. The S&P 500 also rose, gaining, 0.97% to 4,953.70. Communication services shares rose by 4.1% on Friday.
Clorox Posts Upbeat Earnings, Joins Cigna, Deckers Outdoor And Other Big Stocks Moving Higher On Friday - Cigna Group ( NYSE:CI ) , Deckers Outdoor ( NYSE:DECK ) , Clorox ( NYSE:CLX )
U.S. stocks traded mixed, with the Dow Jones falling over 100 points on Friday. Shares of The Clorox Company CLX shares gained during Friday's session after the company reported better-than-expected second-quarter financial results and raised FY24 adjusted EPS guidance above estimates.
Tyra Biosciences, Inc. Announces $200 Million Private Placement Financing
CARLSBAD, Calif., Feb. 2, 2024 /PRNewswire/ -- Tyra Biosciences, Inc. ( Nasdaq: TYRA ) , a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor ( FGFR ) biology, announced today that it ...
Tyra Biosciences Doses First Patient with TYRA-200 and Provides Positive Updates on TYRA-300
- Initiated SURF201 Phase 1 Study; dosed first patient with TYRA-200- - Cleared multiple dose cohorts in SURF301 and continues to dose escalate with TYRA-300-- Received FDA feedback on TYRA-300 Phase 2 ACH study: IND submission planned for 2H 2024-
Chegg, Perdoceo Education And Other Big Stocks Moving Lower On Monday - ReAlpha Tech Corp ( NASDAQ:AIRE ) , Chegg ( NYSE:CHGG )
U.S. stocks traded higher, with the Dow Jones gaining over 50 points on Monday. Here are some big stocks recording losses in today's session. Yatsen Holding Limited YSG shares tumbled 24.2% to $0.6559. Yatsen Holding is expected to release its unaudited financial results for the third quarter on ...
Urothelial Carcinoma Market is Expected to Showcase a Significant Growth by 2032, Assesses DelveInsight | Key Companies to Look Out - MedPacto, AstraZeneca, EMD Serono, Bayer, Merck, Bristol-Myers Squibb, Inovio, Seagen, Incyte
Urothelial Carcinoma Market is Expected to Showcase a Significant Growth by 2032, Assesses DelveInsight | Key ... PR ...
Here's What Could Help Tyra Biosciences, Inc. ( TYRA ) Maintain Its Recent Price Strength
Tyra Biosciences, Inc. (TYRA) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
Wall Street Analysts Think Tyra Biosciences, Inc. ( TYRA ) Could Surge 52.22%: Read This Before Placing a Bet
The consensus price target hints at a 52.2% upside potential for Tyra Biosciences, Inc. (TYRA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
BJ's Wholesale, Kingsoft Cloud, Zoom Video And Other Big Stocks Moving Lower On Tuesday - Alvotech ( NASDAQ:ALVO ) , Achieve Life Sciences ( NASDAQ:ACHV )
Microvast Holdings, Inc. MVST tumbled 22.3% to $1.71 after the US Energy Department reportedly cancelled contract negotiations for a $200 million award for the company. Achieve Life Sciences, Inc. ACHV dropped 14.7% to $6.95 as the company reported topline results from Phase 3 ORCA-3 trial of ...
What Makes Tyra Biosciences, Inc. ( TYRA ) a Good Fit for 'Trend Investing'
Tyra Biosciences, Inc. (TYRA) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Wall Street Analysts Believe Tyra Biosciences, Inc. ( TYRA ) Could Rally 59.17%: Here's is How to Trade
The average of price targets set by Wall Street analysts indicates a potential upside of 59.2% in Tyra Biosciences, Inc. (TYRA). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the ...
Here's Why 'Trend' Investors Would Love Betting on Tyra Biosciences, Inc. ( TYRA )
Tyra Biosciences, Inc. (TYRA) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
Kennedy-Wilson, Radian Group, BridgeBio Pharma And Other Big Stocks Moving Higher On Monday - Azul ( NYSE:AZUL ) , AST SpaceMobile ( NASDAQ:ASTS )
U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Monday. Here are some big stocks recording gains in today's session. BridgeBio Pharma, Inc. BBIO shares surged 59.5% to $17.34 after the company announced positive data for its phase 2 study of Infigratinib in Achondroplasia.
Should You Buy Tyra Biosciences ( TYRA ) Ahead of Earnings?
Tyra Biosciences (TYRA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
US Stocks Higher, NASDAQ Adds Over 230 Points - Bridger Aerospace Gr ( NASDAQ:BAER ) , Carvana ( NYSE:CVNA )
US stocks traded higher this morning, with the NASDAQ gaining more than 230 points on Thursday. Following the market opening Thursday, the Dow traded up 0.02% to 34,092.96, while the NASDAQ rose 2.00% to 11,816.32. The S&P 500 also rose, gaining 1.05% to 4,119.21.
Dow Dips 300 Points; Snap Shares Plunge
U.S. stocks traded lower midway through trading, with the Dow Jones dropping over 300 points on Wednesday. The Dow traded down 0.91% to 33,774.70 while the NASDAQ fell 0.33% to 11,546.13. The S&P 500 also fell, dropping, 0.41% to 4 4,059.70. Health care shares slipped by just 0.1% on Wednesday.
How Much Upside is Left in Tyra Biosciences, Inc. ( TYRA ) ? Wall Street Analysts Think 184%
The mean of analysts' price targets for Tyra Biosciences, Inc. (TYRA) points to an 184.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Wall Street Analysts Think Tyra Biosciences, Inc. ( TYRA ) Could Surge 179%: Read This Before Placing a Bet
The consensus price target hints at a 178.5% upside potential for Tyra Biosciences, Inc. (TYRA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Micron, Charles River Laboratories And Some Other Big Stocks Moving Higher On Friday - Akero Therapeutics ( NASDAQ:AKRO ) , Arcturus Therapeutics ( NASDAQ:ARCT )
U.S. stocks traded slightly higher, with the Nasdaq Composite gaining more than 80 points on Friday. Here are some big stocks recording gains in today's session. IGM Biosciences, Inc. IGMS surged 18.9% to $23.11. Tyra Biosciences, Inc. TYRA gained 17.7% to $10.33. Benson Hill, Inc.
Tyra Biosciences to Present Preclinical Data on TYRA-300, an FGFR3-selective Inhibitor, at ESMO 2022 Congress
CARLSBAD, Calif., Sept. 5, 2022 /PRNewswire/ -- Tyra Biosciences, Inc. ( Nasdaq: TYRA ) , a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer, today announced that the Company will be presenting ...
Why Everbridge Jumped Over 17%; Here Are 90 Biggest Movers From Friday
Micro Focus International plc MFGP shares surged 92% to close at $6.01 on Friday after the company reached an agreement with OpenText to be acquired for $6 billion. Minerva Neurosciences, Inc. NERV gained 58.2% to settle at $10.33. Point72 Asset Management recently reported an 8.8% passive stake ...
Accolade Shares Jump Around 29%, Here's 75 Biggest Movers From Friday
Omeros Corporation OMER jumped 68.7% to close at $4.64. Clovis Oncology, Inc. CLVS gained 58.3% to settle at $2.85 on Friday. Fast Radius, Inc. FSRD jumped 41.2% to close at $0.8887 after jumping over 37% on Thursday. Fast Radius recently appointed Pat McCusker as President, Interim CFO and John ...
Stocks That Hit 52-Week Lows On Monday
During Monday's trading, 1214 companies set new 52-week lows. The largest company by market cap to set a new 52-week low was Microsoft MSFT. Quoin Pharmaceuticals QNRX was the smallest company by market cap to set a new 52-week low. DexCom DXCM's stock fell the most, as it traded down 76.5% to ...
Stocks That Hit 52-Week Lows On Friday
On Friday, 422 stocks made new 52-week lows. Amazon.com AMZN was the largest firm on a market cap basis to set a new 52-week low. Quoin Pharmaceuticals QNRX was the smallest, in terms of market cap, to set a new 52-week low.
Stocks That Hit 52-Week Lows On Friday
On Friday, 213 companies hit new 52-week lows.
Noteworthy Highlights From Today's 52-Week Lows:
The largest company by market cap to set a new 52-week low was Amazon.com ( NASDAQ:AMZN ) .
The smallest company on a market cap basis to set a new 52-week low was Nova Lifestyle ( NASDAQ:NVFY ) .
Accol
Stocks That Hit 52-Week Lows On Thursday
During Thursday, 849 stocks hit new 52-week lows.
Areas of Significance In Today's 52-Week Lows:
JPMorgan Chase ( NYSE:JPM ) was the largest company by market cap to set a new 52-week low.
Reshape Lifesciences ( NASDAQ:RSLS ) was the smallest company by market cap to set a new 52-week low.
Sio G
Stocks That Hit 52-Week Lows On Friday
On Friday, 431 companies hit new 52-week lows.
Noteworthy Mentions In Today's 52-Week Lows:
The largest company by market cap to hit a new 52-week low was Meta Platforms ( NASDAQ:FB ) .
The smallest company by market cap to set a new 52-week low was AnPac Bio-Medical Science ( NASDAQ:ANPC ) .
Baby
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 236 companies hit new 52-week lows.
Intriguing Points From Today's 52-Week Lows:
Salesforce ( NYSE:CRM ) was the largest firm by market cap to set a new 52-week low.
Vallon Pharmaceuticals ( NASDAQ:VLON ) was the smallest firm by market cap to set a new 52-week low.
Ampio Pharmaceut
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 160 companies hit new 52-week lows.
Areas of Significance In Today's 52-Week Lows:
Walt Disney ( NYSE:DIS ) was the largest firm by market cap to set a new 52-week low.
Vallon Pharmaceuticals ( NASDAQ:VLON ) is the smallest company on a market cap basis to set a new 52-week low.
Ne
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 90 companies set new 52-week lows.
Areas of Significance In Today's 52-Week Lows:
The company with the largest market cap to set a new 52-week low was Nuveen AMT-Free Municipal ( NYSE:NEA ) .
Communications Systems ( NASDAQ:JCS ) was the smallest company in terms of market cap to se
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's session, 454 stocks hit new 52-week lows.
Intriguing Points From Today's 52-Week Lows:
Taiwan Semiconductor ( NYSE:TSM ) was the largest company by market cap to set a new 52-week low.
Dermata Therapeutics ( NASDAQ:DRMA ) was the smallest firm by market cap to set a new 52-week
